SCD and fatty liver disease: Third, H-UDCA/RSV/EZE treatment was more effective in reducing hepatocyte ballooning and mRNA expression of SCD-1 compared with L-UDCA/RSV/EZE treatment in HFD-induced hepatic steatosis.